Related references
Note: Only part of the references are listed.Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation
Hisashi Ishida et al.
HEMATOLOGICAL ONCOLOGY (2022)
Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantation
Yuta Kawahara et al.
TRANSPLANTATION AND CELLULAR THERAPY (2022)
Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Li Xuan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol
Akhil Rajendra et al.
BLOOD ADVANCES (2021)
Current Approaches to Philadelphia Chromosome-Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant
Kunhwa Kim et al.
CURRENT ONCOLOGY REPORTS (2021)
The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
Wei Zhang et al.
CANCER BIOLOGY & MEDICINE (2021)
Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma
Lin Gui et al.
CHINESE JOURNAL OF CANCER RESEARCH (2021)
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia
Guillaume Richard-Carpentier et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia
Wei Guan et al.
LEUKEMIA & LYMPHOMA (2020)
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN)
Andreas Burchert et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas
Akihiro Kitadate et al.
HAEMATOLOGICA (2018)
Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas
Akihiro Kitadate et al.
HAEMATOLOGICA (2018)
HDAC inhibitors as epigenetic regulators for cancer immunotherapy
Mariarosaria Conte et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma
Yasmin Abaza et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
Yuankai Shi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia
Betty Ky Hamilton et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype
Nitin Jain et al.
BLOOD (2016)
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
Y. Shi et al.
ANNALS OF ONCOLOGY (2015)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002
Jan Stary et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
High-Dose Cyclophosphamide for the Treatment of Refractory T-Cell Acute Lymphoblastic Leukemia in Children
Rachel Kobos et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2014)
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
Nicola Goekbuget et al.
BLOOD (2012)
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
Berkley E. Gryder et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia
Meilin Ma et al.
Frontiers of Medicine (2012)
High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation
Nicola Goekbuget et al.
BLOOD (2011)
Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)
Barbara L. Asselin et al.
BLOOD (2011)
Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia
Takaomi Sanda et al.
BLOOD (2010)
Extended triple intrathecal therapy in children with T-cell acute lymphoblastic leukaemia: a report from the Israeli National ALL-Studies
Batia Stark et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Nita L. Seibel et al.
BLOOD (2008)
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: Results from ALL-BFM 90 and 95
Andre Schrauder et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience
JM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
